Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001640334-20-003197
Filing Date
2020-12-31
Accepted
2020-12-31 13:57:14
Documents
3
Period of Report
2020-12-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A lxrp_8ka.htm 8-K/A 19291
2 EX-99.1 lxrp_ex991.htm EX-99.1 13341
3 EX-99.2 lxrp_ex992.htm EX-99.2 267101
  Complete submission text file 0001640334-20-003197.txt   301020
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K/A | Act: 34 | File No.: 000-52138 | Film No.: 201428464
SIC: 2834 Pharmaceutical Preparations